Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 13.04.2021
Morgan Stanley Europe SE
[2021/04/12]Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Vantage Towers AG
Mid-stabilisation Period Announcement
Morgan Stanley Europe SE (contact: James Manson-Bahr; telephone: +49 69 2166 1281) hereby gives notice in accordance with Article 6(2) of C [ … ]
Tue, 13.04.2021
Photon Energy NV
DGAP-Media / 13.04.2021 / 12:45
Photon Energy Increases Its Share in Maryvale Solar Farm Through Asset Swap with Canadian Solar
- Photon Energy increases share in Maryvale Solar Farm through asset swap with Canadian Solar. Photon Energy will complete development of the 160 MWp Maryvale Solar Farm project independently, while Canadian Solar [ … ]
Tue, 13.04.2021
Immunic, Inc.
Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April
NEW YORK, April 13, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced participation in the [ … ]
Tue, 13.04.2021
Newron Pharmaceuticals SpA
Milan, Italy - April 13, 2021 - Newron Pharmaceuticals S.p.A. ('Newron') (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced that its shareholders approved the sole motion on the agenda of the AGM 2021 held today, being [ … ]
Tue, 13.04.2021
Newron Pharmaceuticals S.p.A.
Newron announces AGM 2021 result
Milan, Italy - April 13, 2021 - Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced that its shareholders approved the sole motion on the agenda [ … ]
Tue, 13.04.2021
Fyber N.V.
Berlin, 13 April 2021 - Fyber N.V. ("Fyber" or the "Company", FSE:FBEN) has received a conversion notice for 212 convertible bonds issued by the Company (3.50%, 7/2022, ISIN XS1223161651, the "Bonds") to be converted into equity.
The applicable conversion price is €0.30, resulting in 70,666,666 new shares (15.2% of the issued share capital) to be [ … ]
Tue, 13.04.2021
Lindis Biotech GmbH
LINDIS Biotech Reports Successful Initiation of Clinical Phase I Dose Escalation Study with the Trifunctional Antibody CATUMAXOMAB for Treatment of Non-Muscle-Invasive Bladder Cancer
First dose cohort successfully treated
Study to evaluate safety and initial signals of efficacy in up to 30 patients; results of an interim analysis anticipated in f [ … ]
Tue, 13.04.2021
Atriva Therapeutics GmbH
Atriva Therapeutics Announces Changes to Management
- Olaf Althaus appointed Chief Financial Officer
- Stephan Stenglein, M.D., recently joined as Chief Medical Officer
- Proven track record and 20+ years of experience in their respective fields of expertise
Tübingen (Germany), April 13, 2021 - Atriva Therapeutics GmbH, a biopharmaceutical comp [ … ]
Tue, 13.04.2021
Armacell
Press release
Armacell and METYX pursue joint business opportunities in Turkey
- Strengthening Armacell's position in the Turkish composite industry
- PET-based foam core kitting operations for wind turbine manufacturing
- Armacell's 7th global PET foaming line to be installed in Turkey
Luxembourg/Thimister, 13 April 2021 - Armacell, a glob [ … ]
Tue, 13.04.2021
Your Family Entertainment AG
Corporate News Your Family Entertainment AG (WKN A161N1; ISIN DE000A161N14)
Munich, April 13, 2021German-language children's and family channel Fix&Foxi TV expands its coverage in Switzerland
Fix&Foxi TV is now available on Swisscom's "blue TV" platform. Subscribers of the "Top Deutsch+" package can now access the award-winning Fix&Fox [ … ]